Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

808
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
808
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

1.2K
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tau20-RETROmapping System Identifies Driver-Like Activation Patterns in Real-Time During Persistent Atrial Fibrillation.

Circulation. Arrhythmia and electrophysiology·2026
Same author

Hospitalization profiles and complications across ICD and CRT-D implantations in Germany: data from the VIDEO study.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Nationwide Multicentric Analysis Regarding In-Hospital Complications After Catheter Ablation of Cardiac Arrhythmias.

Journal of cardiovascular development and disease·2026
Same author

Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation.

The New England journal of medicine·2026
Same author

Real-world outcomes of Left Atrial Appendage Occlusion with the Amplatzer™ Amulet™: a multicentre observational registry from Southeast Asia.

BMC cardiovascular disorders·2026
Same author

Real word data with no evidence for additional left atrial substrate modification at first PVI procedure in patients with persistent atrial fibrillation - Results from the German Ablation registry.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026

Related Experiment Video

Updated: Feb 20, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.2K

[Current indications for left atrial appendage occlusion].

Clemens Jilek1, Thorsten Lewalter2

  • 1Internistisches Klinikum München Süd, Peter-Osypka-Herzzentrum München, Am Isarkanal 36, 81379, München, Deutschland. clemens.jilek@ikms.de.

Herzschrittmachertherapie & Elektrophysiologie
|October 27, 2017
PubMed
Summary
This summary is machine-generated.

Left atrial appendage (LAA) occlusion can lower bleeding risk in atrial fibrillation patients. This study clarifies LAA occluder indications and presents a decision strategy for clinical practice.

Keywords:
Atrial fibrillationIndicationLeft atrial appendage occlusionPreventionStroke

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.6K
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.4K

Related Experiment Videos

Last Updated: Feb 20, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.2K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.6K
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.4K

Area of Science:

  • Cardiology
  • Medical Devices
  • Clinical Practice Guidelines

Background:

  • Atrial fibrillation patients face a dual risk of stroke and bleeding.
  • Left atrial appendage (LAA) occlusion is a potential intervention to mitigate bleeding risk.
  • Existing guidelines require clarification for optimal LAA occluder use.

Purpose of the Study:

  • To define the indications for LAA occlusion devices.
  • To present a clear decision-making strategy for LAA occlusion in clinical practice.
  • To align with European Heart Rhythm Association (EHRA) consensus.

Main Methods:

  • Literature analysis of existing studies on LAA occlusion.
  • Integration of the European Heart Rhythm Association (EHRA) Consensus Document.
  • Development of a practical clinical decision strategy.

Main Results:

  • Clearer indications for LAA occluder implantation have been established.
  • A structured approach for patient selection and decision-making is provided.
  • The strategy aims to optimize the use of LAA occlusion therapy.

Conclusions:

  • LAA occlusion offers a viable option for managing bleeding risk in select atrial fibrillation patients.
  • The presented strategy facilitates informed clinical decisions regarding LAA occluder use.
  • This work supports evidence-based practice for LAA occlusion therapy.